Azienda Ospedaliera S. Maria - Terni; Oncologia

Terni, Umbria 05100

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Carcinoma, Transitional Cell

Studies at this site

• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early
• A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer — Completed